Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia

Silvia Rasi, Hossein Khiabanian, Carmela Ciardullo, Lodovico Terzi-di-Bergamo, Sara Monti, Valeria Spina, Alessio Bruscaggin, Michaela Cerri, Clara Deambrogi, Lavinia Martuscelli, Alessandra Biasi, Elisa Spaccarotella, Lorenzo de Paoli, Valter Gattei, Robin Foà, Raul Rabadan, Gianluca Gaidano, Davide Rossi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)101-135
Number of pages35
JournalHaematologica
Volume101
Issue number4
DOIs
Publication statusPublished - Mar 31 2016

Keywords

  • BIRC3
  • Chronic lymphocytic leukemia
  • Evolution
  • Frequency
  • NOTCH1
  • Prognostic impact
  • SF3B1
  • Subclones
  • TP53

ASJC Scopus subject areas

  • Hematology

Cite this

Rasi, S., Khiabanian, H., Ciardullo, C., Terzi-di-Bergamo, L., Monti, S., Spina, V., Bruscaggin, A., Cerri, M., Deambrogi, C., Martuscelli, L., Biasi, A., Spaccarotella, E., de Paoli, L., Gattei, V., Foà, R., Rabadan, R., Gaidano, G., & Rossi, D. (2016). Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia. Haematologica, 101(4), 101-135. https://doi.org/10.3324/haematol.2015.136051